Skip to main content

Advertisement

SpringerLink
Log in

Ambulatory factors influencing pulmonary artery pressure waveforms and implications for clinical practice

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

CardioMEMS, a remote pulmonary artery pressure monitoring system, provides waveform patterns for the ambulatory heart failure patient. These waveforms provide significant insights into patient volume and clinical management. We aim to provide a foundation for understanding the determinants of waveform characteristics and provide practical examples illustrating how to interpret and integrate common scenario waveforms into clinical decision-making. A total of three groups of relevant scenarios were included namely (a) location and activity at time of waveform transmission, (b) impact of contemporary interventions, and (c) arrhythmias. We illustrate that waveform analysis can be individualized to each patient’s care strategy in the appropriate clinical context to help guide clinical decision-making.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Truby LK, Rogers JG (2020) Advanced heart failure: epidemiology, diagnosis, and therapeutic approaches. JACC Heart failure 8(7):523–536. https://doi.org/10.1016/j.jchf.2020.01.014

    Article  PubMed  Google Scholar 

  2. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, Nichol G, Pham M, Piña IL, Trogdon JG, Committee AHAAC, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Radiology and Intervention, Council on Clinical Cardiology, Council on Epidemiology and Prevention, & Stroke Council (2013) Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 6(3):606–619. https://doi.org/10.1161/HHF.0b013e318291329a

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Cook C, Cole G, Asaria P, Jabbour R, Francis DP (2014) The annual global economic burden of heart failure. Int J Cardiol 171(3):368–376. https://doi.org/10.1016/j.ijcard.2013.12.028

    Article  PubMed  Google Scholar 

  4. Zile MR, Bourge RC, Bennett TD, Stevenson LW, Cho YK, Adamson PB, Aaron MF, Aranda JM Jr, Abraham WT, Smart FW, Kueffer FJ (2008) Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trial. J Cardiac Fail 14(10):816–823. https://doi.org/10.1016/j.cardfail.2008.07.235

    Article  Google Scholar 

  5. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, Zile MR, Smith AL, Smart FW, O’Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW, COMPASS-HF Study Group (2008) Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 51(11):1073–1079. https://doi.org/10.1016/j.jacc.2007.10.061

    Article  PubMed  Google Scholar 

  6. Mangi MA, Rehman H, Rafique M, Illovsky M (2017) Ambulatory heart failure monitoring: a systemic review. Cureus 9(4):e1174. https://doi.org/10.7759/cureus.1174

    Article  PubMed  PubMed Central  Google Scholar 

  7. Schmier JK, Ong KL, Fonarow GC (2017) Cost-effectiveness of remote cardiac monitoring with the CardioMEMS heart failure system. Clin Cardiol 40(7):430–436. https://doi.org/10.1002/clc.22696

    Article  PubMed  PubMed Central  Google Scholar 

  8. Martinson M, Bharmi R, Dalal N, Abraham WT, Adamson PB (2017) Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial. Eur J Heart Fail 19(5):652–660. https://doi.org/10.1002/ejhf.642

    Article  PubMed  Google Scholar 

  9. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS, CHAMPION Trial Study Group (2011) Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet (London, England) 377(9766):658–666. https://doi.org/10.1016/S0140-6736(11)60101-3

    Article  Google Scholar 

  10. Shavelle DM, Desai AS, Abraham WT, Bourge RC, Raval N, Rathman LD, Heywood JT, Jermyn RA, Pelzel J, Jonsson OT, Costanzo MR, Henderson JD, Brett ME, Adamson PB, Stevenson LW, CardioMEMS Post-Approval Study Investigators (2020) Lower rates of heart failure and all-cause hospitalizations during pulmonary artery pressure-guided therapy for ambulatory heart failure: one-year outcomes from the CardioMEMS post-approval study. Circ Heart Fail 13(8)

  11. Adamson PB, Abraham WT, Aaron M, Aranda JM Jr, Bourge RC, Smith A, Stevenson LW, Bauman JG, Yadav JS (2011) CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Cardiac Fail 17(1):3–10. https://doi.org/10.1016/j.cardfail.2010.08.002

    Article  Google Scholar 

  12. Naeije R, Gerges M, Vachiery JL, Caravita S, Gerges C, Lang IM (2017) Hemodynamic phenotyping of pulmonary hypertension in left heart failure. Circ Heart Fail 10(9):e004082. https://doi.org/10.1161/CIRCHEARTFAILURE.117.004082

    Article  PubMed  Google Scholar 

  13. Abraham J, McCann PJ, Guglin ME et al (2020) Management of the patient with heart failure and an implantable pulmonary artery hemodynamic sensor. Curr Cardiovasc Risk Rep 14:12. https://doi.org/10.1007/s12170-020-00646-4

    Article  Google Scholar 

  14. Jermyn R, Alam A, Kvasic J, Saeed O, Jorde U (2017) Hemodynamic-guided heart-failure management using a wireless implantable sensor: infrastructure, methods, and results in a community heart failure disease-management program. Clin Cardiol 40(3):170–176. https://doi.org/10.1002/clc.22643

    Article  PubMed  Google Scholar 

  15. CardioMEMS™ HF System PA Sensor and Delivery System. User’s Manual. Accessed October 20th 2021

  16. Letourneau MM, Brancheau D, Estes J, Zughaib M (2020) Take me higher: a case of heart failure at high altitude detected using the CardioMEMS™ HF System. Am J Case Rep 21:e922857. https://doi.org/10.12659/AJCR.922857

  17. Naeije R, Saggar R, Badesch D, Rajagopalan S, Gargani L, Rischard F, Ferrara F, Marra AM, D’ Alto M, Bull TM, Saggar R, Grünig E, Bossone E (2018) Exercise-induced pulmonary hypertension: translating pathophysiological concepts into clinical practice. Chest 154(1):10–15. https://doi.org/10.1016/j.chest.2018.01.022

    Article  PubMed  Google Scholar 

  18. Greene SJ, Butler J, Fonarow GC (2021) Simultaneous or rapid sequence initiation of quadruple medical therapy for heart failure-optimizing therapy with the need for speed. JAMA cardiology 6(7):743–744. https://doi.org/10.1001/jamacardio.2021.0496

    Article  PubMed  Google Scholar 

  19. Molina EJ, Shah P, Kiernan MS, Cornwell WK 3rd, Copeland H, Takeda K, Fernandez FG, Badhwar V, Habib RH, Jacobs JP, Koehl D, Kirklin JK, Pagani FD, Cowger JA (2021) The Society of Thoracic Surgeons Intermacs 2020 Annual Report. Ann Thorac Surg 111(3):778–792. https://doi.org/10.1016/j.athoracsur.2020.12.038

    Article  PubMed  Google Scholar 

  20. Brinkley DM, Guglin ME, Bennett MK, Redfield MM, Abraham WT, Brett ME, Dirckx N, Adamson PB, Stevenson LW (2021) Pulmonary artery pressure monitoring effectively guides management to reduce heart failure hospitalizations in obesity. JACC Heart failure 9(11):784–794. https://doi.org/10.1016/j.jchf.2021.05.020

    Article  PubMed  Google Scholar 

  21. Alam A, Van Zyl J, Nayyar N, Hall S, Jermyn R (2021) Improvement in metabolic co-morbidities after implantation of CardioMEMS in patients with heart failure with preserved ejection fraction phenotype. J Clin Med 10(19):4308. https://doi.org/10.3390/jcm10194308

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Nassif ME, Qintar M, Windsor SL, Jermyn R, Shavelle DM, Tang F, Lamba S, Bhatt K, Brush J, Civitello A, Gordon R, Jonsson O, Lampert B, Pelzel J, Kosiborod MN (2021) Empagliflozin effects on pulmonary artery pressure in patients with heart failure: results from the EMBRACE-HF trial. Circulation 143(17):1673–1686. https://doi.org/10.1161/CIRCULATIONAHA.120.052503

    Article  CAS  PubMed  Google Scholar 

  23. Aminian A, Wilson R, Zajichek A, Tu C, Wolski KE, Schauer PR, Kattan MW, Nissen SE, Brethauer SA (2021) Cardiovascular outcomes in patients with type 2 diabetes and obesity: comparison of gastric bypass, sleeve gastrectomy, and usual care. Diabetes Care 44(11):2552–2563. https://doi.org/10.2337/dc20-3023

    Article  CAS  PubMed  Google Scholar 

  24. Rich JD, Burkhoff D (2017) HVAD flow waveform morphologies: theoretical foundation and implications for clinical practice. ASAIO J 63(5):526–535. https://doi.org/10.1097/MAT.0000000000000557

Download references

Author information

Authors and Affiliations

  1. Department of Advanced Heart Failure, Baylor University Medical Center, Dallas, TX, USA

    Amit Alam

  2. Texas A&M University College of Medicine, Dallas, TX, USA

    Amit Alam

  3. St. Francis Hospital, Roslyn, Long Island, NY, USA

    Rita Jermyn

  4. Department of Cardiovascular Medicine, School of Medicine, University of Kansas, Kansas City, KS, USA

    Ioannis Mastoris, Leslie Steinkamp & Andrew J. Sauer

  5. Houston Methodist DeBakey Heart and Vascular Institute, Houston Methodist Hospital, Houston, TX, USA

    Arvind Bhimaraj

Authors
  1. Amit Alam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rita Jermyn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ioannis Mastoris
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leslie Steinkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Arvind Bhimaraj
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Andrew J. Sauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amit Alam.

Ethics declarations

Conflict of interest

Amit Alam: no conflicts of interest or financial ties to disclose. Rita Jermyn: Abbott consultant and no longer. Ioannis Mastoris: no conflicts of interest or financial ties to disclose. Leslie Steinkamp: has received consulting fees from Boston Scientific and Edwards Life Sciences. Arvind Bhimaraj: Abbott (speaker/consulting); Abiomed (speaker); Care Dx (Advisory Board); AstraZenec (speaker); Maquet (speaker) Andrew Sauer: honorarium for consulting work done with Medtronic, Boston Scientific, Abbott, Edwards Life Sciences, Impulse Dynamics, and General Prognostics.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alam, A., Jermyn, R., Mastoris, I. et al. Ambulatory factors influencing pulmonary artery pressure waveforms and implications for clinical practice. Heart Fail Rev 27, 2083–2093 (2022). https://doi.org/10.1007/s10741-022-10249-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-022-10249-3

Keywords

Search

Navigation